Skip to main content
Clinical Trials/CTRI/2025/10/096134
CTRI/2025/10/096134Not yet recruitingPhase 2

Effectiveness of the Bates method v/s Oculomotor exercises on visual acuity and eye fatigue in individuals with Digital eye strain: A Randomized clinical trial

Harshawardhan kudale1 site in 1 country68 target enrollmentStarted: November 11, 2025Last updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
68
Locations
1
Primary Endpoint
Patient satisfaction scale

Study Overview

Brief Summary

This randomized clinical trial investigates the effectiveness of the Bates method compared to oculomotor rehabilitation in improving visual acuity and reducing eye fatigue in individuals experiencing digital eye strain (DES). DES is a common condition among frequent digital device users, characterized by symptoms such as eye discomfort, blurred vision, dryness, and headaches, resulting from prolonged screen exposure. The study targets computer users aged 18 to 40 years, with a particular focus on young adults aged 18-25.The research methodology involves assigning participants to either the Bates method group or the oculomotor rehabilitation group. The Bates method, a vision improvement technique developed by William H. Bates, aims to reduce eye muscle strain through relaxation exercises. Oculomotor rehabilitation focuses on enhancing eye muscle coordination, focus flexibility, and reducing symptoms of eye strain through targeted exercises. Visual acuity measurements are conducted using standardized tools such as the Snellen chart and dynamic visual acuity tests, while eye fatigue levels are evaluated using validated questionnaires like the Computer Vision Syndrome Questionnaire (CVS-Q).

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Investigator Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 40.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Age group between 18-40years,People using Digital devices/viewing screen or with the screen time for 6 hours or more,CVS-Q score higher than or equal to 6 ,Willingness to participate.

Exclusion Criteria

  • History of Systemic ocular pathology (diabetes mellitus, hypertension), History of Strabismic anomaly(hypertropia, hypotropia), People undergoing any kind of vision therapy, History of Hypermetropia, Myopia, Cataract, Glaucoma, History of Neurological disorders(Myasthenia gravis, Stroke, TBI, Optic neuritis).

Outcomes

Primary Outcomes

Patient satisfaction scale

Time Frame: which will be assessed at baseline and after 3 weeks

Secondary Outcomes

  • Eye risk level questionnaire(which will be assessed at baseline & after 3 weeks)
  • Dynamic Visual Acuity(which will be assessed at baseline & after 3 weeks)

Investigators

Sponsor
Harshawardhan kudale
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr sushmita badiger

KLES Institute of Physiotherapy Belgaum

Study Sites (1)

Loading locations...

Similar Trials